Global PSMA Imaging Agent for Prostate Cancer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global PSMA Imaging Agent for Prostate Cancer market size was valued at US$ 1821 million in 2025 and is forecast to a readjusted size of US$ 2915 million by 2032 with a CAGR of 6.9% during review period.
In 2025, the global production of PSMA imaging agent for prostate cancer reached 3.5394 million units, with an average selling price of $500 per unit. The annual production capacity of PSMA imaging agents for prostate cancer worldwide is approximately 5 million units, with a gross margin of about 30.4%. PSMA imaging agent for prostate cancer is a radiotracer that targets prostate?specific membrane antigen (PSMA) and enables molecular?level imaging of prostate cancer lesions via positron emission tomography (PET). PSMA is highly expressed on the surface of prostate cancer cells. After the imaging agent specifically binds to it, PET/CT or PET/MRI equipment is used to detect radioactive signals, thereby enabling high?sensitivity localization of primary lesions, detection of metastases, and assessment of recurrence. It is currently an important tool in precision diagnosis and treatment of prostate cancer. The upstream of PSMA imaging agents for prostate cancer includes radionuclides (such as gallium?68, fluorine?18, etc.), PSMA?targeting ligands (small molecules/peptides/antibodies), and nanocarriers/chelators, among others. The midstream consists of manufacturers of PSMA imaging agents for prostate cancer, while the downstream is mainly used in nuclear medicine and molecular imaging, precision tumor diagnosis, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA imaging agent for prostate cancer is in a phase of rapid development. As a revolutionary molecular imaging tool, it has been widely integrated into clinical management pathways for prostate cancer, playing a key role especially in initial staging, detection of biochemical recurrence, and formulation of treatment strategies. With the growing availability of PET/CT and PET/MRI equipment and the continuous emergence of novel PSMA ligands, the clinical applications of this imaging agent are steadily expanding. Meanwhile, the rise of the theranostics concept means that PSMA imaging agents for prostate cancer are not only used for diagnosis but are also beginning to be linked with PSMA?targeted radionuclide therapy, ushering prostate cancer into a new era of precision medicine. Furthermore, improvements in regulatory approval and standardized production requirements for radiopharmaceuticals, along with gradual optimization of reimbursement policies, have further contributed to the maturation and growth of this market.
Report Scope
This report is a detailed and comprehensive analysis for global PSMA Imaging Agent for Prostate Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PSMA Imaging Agent for Prostate Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe PSMA Imaging Agent for Prostate Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PSMA Imaging Agent for Prostate Cancer, with price, sales quantity, revenue, and global market share of PSMA Imaging Agent for Prostate Cancer from 2021 to 2026.
Chapter 3, the PSMA Imaging Agent for Prostate Cancer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PSMA Imaging Agent for Prostate Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and PSMA Imaging Agent for Prostate Cancer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PSMA Imaging Agent for Prostate Cancer.
Chapter 14 and 15, to describe PSMA Imaging Agent for Prostate Cancer sales channel, distributors, customers, research findings and conclusion.
In 2025, the global production of PSMA imaging agent for prostate cancer reached 3.5394 million units, with an average selling price of $500 per unit. The annual production capacity of PSMA imaging agents for prostate cancer worldwide is approximately 5 million units, with a gross margin of about 30.4%. PSMA imaging agent for prostate cancer is a radiotracer that targets prostate?specific membrane antigen (PSMA) and enables molecular?level imaging of prostate cancer lesions via positron emission tomography (PET). PSMA is highly expressed on the surface of prostate cancer cells. After the imaging agent specifically binds to it, PET/CT or PET/MRI equipment is used to detect radioactive signals, thereby enabling high?sensitivity localization of primary lesions, detection of metastases, and assessment of recurrence. It is currently an important tool in precision diagnosis and treatment of prostate cancer. The upstream of PSMA imaging agents for prostate cancer includes radionuclides (such as gallium?68, fluorine?18, etc.), PSMA?targeting ligands (small molecules/peptides/antibodies), and nanocarriers/chelators, among others. The midstream consists of manufacturers of PSMA imaging agents for prostate cancer, while the downstream is mainly used in nuclear medicine and molecular imaging, precision tumor diagnosis, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA imaging agent for prostate cancer is in a phase of rapid development. As a revolutionary molecular imaging tool, it has been widely integrated into clinical management pathways for prostate cancer, playing a key role especially in initial staging, detection of biochemical recurrence, and formulation of treatment strategies. With the growing availability of PET/CT and PET/MRI equipment and the continuous emergence of novel PSMA ligands, the clinical applications of this imaging agent are steadily expanding. Meanwhile, the rise of the theranostics concept means that PSMA imaging agents for prostate cancer are not only used for diagnosis but are also beginning to be linked with PSMA?targeted radionuclide therapy, ushering prostate cancer into a new era of precision medicine. Furthermore, improvements in regulatory approval and standardized production requirements for radiopharmaceuticals, along with gradual optimization of reimbursement policies, have further contributed to the maturation and growth of this market.
Report Scope
This report is a detailed and comprehensive analysis for global PSMA Imaging Agent for Prostate Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSMA Imaging Agent for Prostate Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for PSMA Imaging Agent for Prostate Cancer
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PSMA Imaging Agent for Prostate Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 68Ga
- 18F
- First Generation
- Second Generation
- Active Targeting
- Passive Targeting
- Nuclear Medicine and Molecular Imaging
- Precision Oncology Diagnostics
- Radiopharmaceuticals and Radiopharmaceuticals
- Lantheus
- Telix Pharmaceuticals
- Novartis
- Blue Earth Diagnostics?Bracco?
- Sinotau
- DC PHARMA
- Clarity Pharmaceuticals
- Hengrui Pharma
- CRAND PHARMACEUTICAL
- Norroy Bioscience
- HUAYI RADIOPHARMACEUTICALS
- Yunhe Pharma
- C Ray Therapeutics
- Curium Holding France S.A.S.
- ABX advanced biochemical compounds GmbH
- Isotopia Molecular Imaging Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe PSMA Imaging Agent for Prostate Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PSMA Imaging Agent for Prostate Cancer, with price, sales quantity, revenue, and global market share of PSMA Imaging Agent for Prostate Cancer from 2021 to 2026.
Chapter 3, the PSMA Imaging Agent for Prostate Cancer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PSMA Imaging Agent for Prostate Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and PSMA Imaging Agent for Prostate Cancer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PSMA Imaging Agent for Prostate Cancer.
Chapter 14 and 15, to describe PSMA Imaging Agent for Prostate Cancer sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 68Ga
1.3.3 18F
1.4 Market Analysis by Core Carrier Materials
1.4.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Core Carrier Materials: 2021 Versus 2025 Versus 2032
1.4.2 First Generation
1.4.3 Second Generation
1.5 Market Analysis by Mechanism of Action
1.5.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Mechanism of Action: 2021 Versus 2025 Versus 2032
1.5.2 Active Targeting
1.5.3 Passive Targeting
1.6 Market Analysis by Application
1.6.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Nuclear Medicine and Molecular Imaging
1.6.3 Precision Oncology Diagnostics
1.6.4 Radiopharmaceuticals and Radiopharmaceuticals
1.7 Global PSMA Imaging Agent for Prostate Cancer Market Size & Forecast
1.7.1 Global PSMA Imaging Agent for Prostate Cancer Consumption Value (2021 & 2025 & 2032)
1.7.2 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity (2021-2032)
1.7.3 Global PSMA Imaging Agent for Prostate Cancer Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Lantheus
2.1.1 Lantheus Details
2.1.2 Lantheus Major Business
2.1.3 Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
2.1.4 Lantheus PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Lantheus Recent Developments/Updates
2.2 Telix Pharmaceuticals
2.2.1 Telix Pharmaceuticals Details
2.2.2 Telix Pharmaceuticals Major Business
2.2.3 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
2.2.4 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Telix Pharmaceuticals Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
2.3.4 Novartis PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis Recent Developments/Updates
2.4 Blue Earth Diagnostics?Bracco?
2.4.1 Blue Earth Diagnostics?Bracco? Details
2.4.2 Blue Earth Diagnostics?Bracco? Major Business
2.4.3 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
2.4.4 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Blue Earth Diagnostics?Bracco? Recent Developments/Updates
2.5 Sinotau
2.5.1 Sinotau Details
2.5.2 Sinotau Major Business
2.5.3 Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
2.5.4 Sinotau PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sinotau Recent Developments/Updates
2.6 DC PHARMA
2.6.1 DC PHARMA Details
2.6.2 DC PHARMA Major Business
2.6.3 DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
2.6.4 DC PHARMA PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DC PHARMA Recent Developments/Updates
2.7 Clarity Pharmaceuticals
2.7.1 Clarity Pharmaceuticals Details
2.7.2 Clarity Pharmaceuticals Major Business
2.7.3 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
2.7.4 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Clarity Pharmaceuticals Recent Developments/Updates
2.8 Hengrui Pharma
2.8.1 Hengrui Pharma Details
2.8.2 Hengrui Pharma Major Business
2.8.3 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
2.8.4 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hengrui Pharma Recent Developments/Updates
2.9 CRAND PHARMACEUTICAL
2.9.1 CRAND PHARMACEUTICAL Details
2.9.2 CRAND PHARMACEUTICAL Major Business
2.9.3 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
2.9.4 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CRAND PHARMACEUTICAL Recent Developments/Updates
2.10 Norroy Bioscience
2.10.1 Norroy Bioscience Details
2.10.2 Norroy Bioscience Major Business
2.10.3 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
2.10.4 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Norroy Bioscience Recent Developments/Updates
2.11 HUAYI RADIOPHARMACEUTICALS
2.11.1 HUAYI RADIOPHARMACEUTICALS Details
2.11.2 HUAYI RADIOPHARMACEUTICALS Major Business
2.11.3 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
2.11.4 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
2.12 Yunhe Pharma
2.12.1 Yunhe Pharma Details
2.12.2 Yunhe Pharma Major Business
2.12.3 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
2.12.4 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Yunhe Pharma Recent Developments/Updates
2.13 C Ray Therapeutics
2.13.1 C Ray Therapeutics Details
2.13.2 C Ray Therapeutics Major Business
2.13.3 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
2.13.4 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 C Ray Therapeutics Recent Developments/Updates
2.14 Curium Holding France S.A.S.
2.14.1 Curium Holding France S.A.S. Details
2.14.2 Curium Holding France S.A.S. Major Business
2.14.3 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
2.14.4 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Curium Holding France S.A.S. Recent Developments/Updates
2.15 ABX advanced biochemical compounds GmbH
2.15.1 ABX advanced biochemical compounds GmbH Details
2.15.2 ABX advanced biochemical compounds GmbH Major Business
2.15.3 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
2.15.4 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 ABX advanced biochemical compounds GmbH Recent Developments/Updates
2.16 Isotopia Molecular Imaging Ltd.
2.16.1 Isotopia Molecular Imaging Ltd. Details
2.16.2 Isotopia Molecular Imaging Ltd. Major Business
2.16.3 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
2.16.4 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Isotopia Molecular Imaging Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PSMA IMAGING AGENT FOR PROSTATE CANCER BY MANUFACTURER
3.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Manufacturer (2021-2026)
3.2 Global PSMA Imaging Agent for Prostate Cancer Revenue by Manufacturer (2021-2026)
3.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 PSMA Imaging Agent for Prostate Cancer Manufacturer Market Share in 2025
3.4.3 Top 6 PSMA Imaging Agent for Prostate Cancer Manufacturer Market Share in 2025
3.5 PSMA Imaging Agent for Prostate Cancer Market: Overall Company Footprint Analysis
3.5.1 PSMA Imaging Agent for Prostate Cancer Market: Region Footprint
3.5.2 PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
3.5.3 PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PSMA Imaging Agent for Prostate Cancer Market Size by Region
4.1.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2032)
4.1.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2032)
4.1.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2032)
4.2 North America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.3 Europe PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.4 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.5 South America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.6 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
5.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2021-2032)
5.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
6.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2021-2032)
6.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
7.2 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
7.3 North America PSMA Imaging Agent for Prostate Cancer Market Size by Country
7.3.1 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
7.3.2 North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
8.2 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
8.3 Europe PSMA Imaging Agent for Prostate Cancer Market Size by Country
8.3.1 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
8.3.2 Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Market Size by Region
9.3.1 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
10.2 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
10.3 South America PSMA Imaging Agent for Prostate Cancer Market Size by Country
10.3.1 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
10.3.2 South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Market Size by Country
11.3.1 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 PSMA Imaging Agent for Prostate Cancer Market Drivers
12.2 PSMA Imaging Agent for Prostate Cancer Market Restraints
12.3 PSMA Imaging Agent for Prostate Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PSMA Imaging Agent for Prostate Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of PSMA Imaging Agent for Prostate Cancer
13.3 PSMA Imaging Agent for Prostate Cancer Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PSMA Imaging Agent for Prostate Cancer Typical Distributors
14.3 PSMA Imaging Agent for Prostate Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 68Ga
1.3.3 18F
1.4 Market Analysis by Core Carrier Materials
1.4.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Core Carrier Materials: 2021 Versus 2025 Versus 2032
1.4.2 First Generation
1.4.3 Second Generation
1.5 Market Analysis by Mechanism of Action
1.5.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Mechanism of Action: 2021 Versus 2025 Versus 2032
1.5.2 Active Targeting
1.5.3 Passive Targeting
1.6 Market Analysis by Application
1.6.1 Overview: Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Nuclear Medicine and Molecular Imaging
1.6.3 Precision Oncology Diagnostics
1.6.4 Radiopharmaceuticals and Radiopharmaceuticals
1.7 Global PSMA Imaging Agent for Prostate Cancer Market Size & Forecast
1.7.1 Global PSMA Imaging Agent for Prostate Cancer Consumption Value (2021 & 2025 & 2032)
1.7.2 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity (2021-2032)
1.7.3 Global PSMA Imaging Agent for Prostate Cancer Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Lantheus
2.1.1 Lantheus Details
2.1.2 Lantheus Major Business
2.1.3 Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
2.1.4 Lantheus PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Lantheus Recent Developments/Updates
2.2 Telix Pharmaceuticals
2.2.1 Telix Pharmaceuticals Details
2.2.2 Telix Pharmaceuticals Major Business
2.2.3 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
2.2.4 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Telix Pharmaceuticals Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
2.3.4 Novartis PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis Recent Developments/Updates
2.4 Blue Earth Diagnostics?Bracco?
2.4.1 Blue Earth Diagnostics?Bracco? Details
2.4.2 Blue Earth Diagnostics?Bracco? Major Business
2.4.3 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
2.4.4 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Blue Earth Diagnostics?Bracco? Recent Developments/Updates
2.5 Sinotau
2.5.1 Sinotau Details
2.5.2 Sinotau Major Business
2.5.3 Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
2.5.4 Sinotau PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sinotau Recent Developments/Updates
2.6 DC PHARMA
2.6.1 DC PHARMA Details
2.6.2 DC PHARMA Major Business
2.6.3 DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
2.6.4 DC PHARMA PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 DC PHARMA Recent Developments/Updates
2.7 Clarity Pharmaceuticals
2.7.1 Clarity Pharmaceuticals Details
2.7.2 Clarity Pharmaceuticals Major Business
2.7.3 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
2.7.4 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Clarity Pharmaceuticals Recent Developments/Updates
2.8 Hengrui Pharma
2.8.1 Hengrui Pharma Details
2.8.2 Hengrui Pharma Major Business
2.8.3 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
2.8.4 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Hengrui Pharma Recent Developments/Updates
2.9 CRAND PHARMACEUTICAL
2.9.1 CRAND PHARMACEUTICAL Details
2.9.2 CRAND PHARMACEUTICAL Major Business
2.9.3 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
2.9.4 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 CRAND PHARMACEUTICAL Recent Developments/Updates
2.10 Norroy Bioscience
2.10.1 Norroy Bioscience Details
2.10.2 Norroy Bioscience Major Business
2.10.3 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
2.10.4 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Norroy Bioscience Recent Developments/Updates
2.11 HUAYI RADIOPHARMACEUTICALS
2.11.1 HUAYI RADIOPHARMACEUTICALS Details
2.11.2 HUAYI RADIOPHARMACEUTICALS Major Business
2.11.3 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
2.11.4 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
2.12 Yunhe Pharma
2.12.1 Yunhe Pharma Details
2.12.2 Yunhe Pharma Major Business
2.12.3 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
2.12.4 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Yunhe Pharma Recent Developments/Updates
2.13 C Ray Therapeutics
2.13.1 C Ray Therapeutics Details
2.13.2 C Ray Therapeutics Major Business
2.13.3 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
2.13.4 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 C Ray Therapeutics Recent Developments/Updates
2.14 Curium Holding France S.A.S.
2.14.1 Curium Holding France S.A.S. Details
2.14.2 Curium Holding France S.A.S. Major Business
2.14.3 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
2.14.4 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Curium Holding France S.A.S. Recent Developments/Updates
2.15 ABX advanced biochemical compounds GmbH
2.15.1 ABX advanced biochemical compounds GmbH Details
2.15.2 ABX advanced biochemical compounds GmbH Major Business
2.15.3 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
2.15.4 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 ABX advanced biochemical compounds GmbH Recent Developments/Updates
2.16 Isotopia Molecular Imaging Ltd.
2.16.1 Isotopia Molecular Imaging Ltd. Details
2.16.2 Isotopia Molecular Imaging Ltd. Major Business
2.16.3 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
2.16.4 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Isotopia Molecular Imaging Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PSMA IMAGING AGENT FOR PROSTATE CANCER BY MANUFACTURER
3.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Manufacturer (2021-2026)
3.2 Global PSMA Imaging Agent for Prostate Cancer Revenue by Manufacturer (2021-2026)
3.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 PSMA Imaging Agent for Prostate Cancer Manufacturer Market Share in 2025
3.4.3 Top 6 PSMA Imaging Agent for Prostate Cancer Manufacturer Market Share in 2025
3.5 PSMA Imaging Agent for Prostate Cancer Market: Overall Company Footprint Analysis
3.5.1 PSMA Imaging Agent for Prostate Cancer Market: Region Footprint
3.5.2 PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
3.5.3 PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PSMA Imaging Agent for Prostate Cancer Market Size by Region
4.1.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2032)
4.1.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2032)
4.1.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2032)
4.2 North America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.3 Europe PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.4 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.5 South America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
4.6 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
5.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2021-2032)
5.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
6.2 Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2021-2032)
6.3 Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
7.2 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
7.3 North America PSMA Imaging Agent for Prostate Cancer Market Size by Country
7.3.1 North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
7.3.2 North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
8.2 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
8.3 Europe PSMA Imaging Agent for Prostate Cancer Market Size by Country
8.3.1 Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
8.3.2 Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Market Size by Region
9.3.1 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
10.2 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
10.3 South America PSMA Imaging Agent for Prostate Cancer Market Size by Country
10.3.1 South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
10.3.2 South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Market Size by Country
11.3.1 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 PSMA Imaging Agent for Prostate Cancer Market Drivers
12.2 PSMA Imaging Agent for Prostate Cancer Market Restraints
12.3 PSMA Imaging Agent for Prostate Cancer Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PSMA Imaging Agent for Prostate Cancer and Key Manufacturers
13.2 Manufacturing Costs Percentage of PSMA Imaging Agent for Prostate Cancer
13.3 PSMA Imaging Agent for Prostate Cancer Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PSMA Imaging Agent for Prostate Cancer Typical Distributors
14.3 PSMA Imaging Agent for Prostate Cancer Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Table 3. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Lantheus Basic Information, Manufacturing Base and Competitors
Table 6. Lantheus Major Business
Table 7. Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
Table 8. Lantheus PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Lantheus Recent Developments/Updates
Table 10. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 11. Telix Pharmaceuticals Major Business
Table 12. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 13. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Telix Pharmaceuticals Recent Developments/Updates
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
Table 18. Novartis PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Novartis Recent Developments/Updates
Table 20. Blue Earth Diagnostics?Bracco? Basic Information, Manufacturing Base and Competitors
Table 21. Blue Earth Diagnostics?Bracco? Major Business
Table 22. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
Table 23. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Blue Earth Diagnostics?Bracco? Recent Developments/Updates
Table 25. Sinotau Basic Information, Manufacturing Base and Competitors
Table 26. Sinotau Major Business
Table 27. Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
Table 28. Sinotau PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sinotau Recent Developments/Updates
Table 30. DC PHARMA Basic Information, Manufacturing Base and Competitors
Table 31. DC PHARMA Major Business
Table 32. DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
Table 33. DC PHARMA PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. DC PHARMA Recent Developments/Updates
Table 35. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Clarity Pharmaceuticals Major Business
Table 37. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 38. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Clarity Pharmaceuticals Recent Developments/Updates
Table 40. Hengrui Pharma Basic Information, Manufacturing Base and Competitors
Table 41. Hengrui Pharma Major Business
Table 42. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 43. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Hengrui Pharma Recent Developments/Updates
Table 45. CRAND PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 46. CRAND PHARMACEUTICAL Major Business
Table 47. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
Table 48. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. CRAND PHARMACEUTICAL Recent Developments/Updates
Table 50. Norroy Bioscience Basic Information, Manufacturing Base and Competitors
Table 51. Norroy Bioscience Major Business
Table 52. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
Table 53. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Norroy Bioscience Recent Developments/Updates
Table 55. HUAYI RADIOPHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 56. HUAYI RADIOPHARMACEUTICALS Major Business
Table 57. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
Table 58. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
Table 60. Yunhe Pharma Basic Information, Manufacturing Base and Competitors
Table 61. Yunhe Pharma Major Business
Table 62. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 63. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Yunhe Pharma Recent Developments/Updates
Table 65. C Ray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. C Ray Therapeutics Major Business
Table 67. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
Table 68. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. C Ray Therapeutics Recent Developments/Updates
Table 70. Curium Holding France S.A.S. Basic Information, Manufacturing Base and Competitors
Table 71. Curium Holding France S.A.S. Major Business
Table 72. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 73. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Curium Holding France S.A.S. Recent Developments/Updates
Table 75. ABX advanced biochemical compounds GmbH Basic Information, Manufacturing Base and Competitors
Table 76. ABX advanced biochemical compounds GmbH Major Business
Table 77. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
Table 78. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. ABX advanced biochemical compounds GmbH Recent Developments/Updates
Table 80. Isotopia Molecular Imaging Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Isotopia Molecular Imaging Ltd. Major Business
Table 82. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 83. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Isotopia Molecular Imaging Ltd. Recent Developments/Updates
Table 85. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 86. Global PSMA Imaging Agent for Prostate Cancer Revenue by Manufacturer (2021-2026) & (USD Million)
Table 87. Global PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 88. Market Position of Manufacturers in PSMA Imaging Agent for Prostate Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 89. Head Office and PSMA Imaging Agent for Prostate Cancer Production Site of Key Manufacturer
Table 90. PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
Table 91. PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
Table 92. PSMA Imaging Agent for Prostate Cancer New Market Entrants and Barriers to Market Entry
Table 93. PSMA Imaging Agent for Prostate Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 95. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2026) & (K Units)
Table 96. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2027-2032) & (K Units)
Table 97. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 98. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 99. Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 100. Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 101. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 102. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 103. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2021-2026) & (USD Million)
Table 104. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2027-2032) & (USD Million)
Table 105. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 106. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 107. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 108. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 109. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 112. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 113. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 114. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 115. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 116. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 117. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 118. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 119. North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 122. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 123. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 124. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 125. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 126. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 127. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 128. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 130. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 131. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2026) & (K Units)
Table 134. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2027-2032) & (K Units)
Table 135. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 136. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 137. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 138. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 139. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 140. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 141. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 142. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 143. South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 144. South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 146. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 147. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 148. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 149. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 150. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 151. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 152. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 153. PSMA Imaging Agent for Prostate Cancer Raw Material
Table 154. Key Manufacturers of PSMA Imaging Agent for Prostate Cancer Raw Materials
Table 155. PSMA Imaging Agent for Prostate Cancer Typical Distributors
Table 156. PSMA Imaging Agent for Prostate Cancer Typical Customers
Table 1. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Table 3. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 4. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Lantheus Basic Information, Manufacturing Base and Competitors
Table 6. Lantheus Major Business
Table 7. Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
Table 8. Lantheus PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Lantheus Recent Developments/Updates
Table 10. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 11. Telix Pharmaceuticals Major Business
Table 12. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 13. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Telix Pharmaceuticals Recent Developments/Updates
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
Table 18. Novartis PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Novartis Recent Developments/Updates
Table 20. Blue Earth Diagnostics?Bracco? Basic Information, Manufacturing Base and Competitors
Table 21. Blue Earth Diagnostics?Bracco? Major Business
Table 22. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
Table 23. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Blue Earth Diagnostics?Bracco? Recent Developments/Updates
Table 25. Sinotau Basic Information, Manufacturing Base and Competitors
Table 26. Sinotau Major Business
Table 27. Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
Table 28. Sinotau PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sinotau Recent Developments/Updates
Table 30. DC PHARMA Basic Information, Manufacturing Base and Competitors
Table 31. DC PHARMA Major Business
Table 32. DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
Table 33. DC PHARMA PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. DC PHARMA Recent Developments/Updates
Table 35. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Clarity Pharmaceuticals Major Business
Table 37. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 38. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Clarity Pharmaceuticals Recent Developments/Updates
Table 40. Hengrui Pharma Basic Information, Manufacturing Base and Competitors
Table 41. Hengrui Pharma Major Business
Table 42. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 43. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Hengrui Pharma Recent Developments/Updates
Table 45. CRAND PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 46. CRAND PHARMACEUTICAL Major Business
Table 47. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
Table 48. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. CRAND PHARMACEUTICAL Recent Developments/Updates
Table 50. Norroy Bioscience Basic Information, Manufacturing Base and Competitors
Table 51. Norroy Bioscience Major Business
Table 52. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
Table 53. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Norroy Bioscience Recent Developments/Updates
Table 55. HUAYI RADIOPHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 56. HUAYI RADIOPHARMACEUTICALS Major Business
Table 57. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
Table 58. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
Table 60. Yunhe Pharma Basic Information, Manufacturing Base and Competitors
Table 61. Yunhe Pharma Major Business
Table 62. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 63. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Yunhe Pharma Recent Developments/Updates
Table 65. C Ray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 66. C Ray Therapeutics Major Business
Table 67. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
Table 68. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. C Ray Therapeutics Recent Developments/Updates
Table 70. Curium Holding France S.A.S. Basic Information, Manufacturing Base and Competitors
Table 71. Curium Holding France S.A.S. Major Business
Table 72. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 73. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Curium Holding France S.A.S. Recent Developments/Updates
Table 75. ABX advanced biochemical compounds GmbH Basic Information, Manufacturing Base and Competitors
Table 76. ABX advanced biochemical compounds GmbH Major Business
Table 77. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
Table 78. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. ABX advanced biochemical compounds GmbH Recent Developments/Updates
Table 80. Isotopia Molecular Imaging Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Isotopia Molecular Imaging Ltd. Major Business
Table 82. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 83. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Isotopia Molecular Imaging Ltd. Recent Developments/Updates
Table 85. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 86. Global PSMA Imaging Agent for Prostate Cancer Revenue by Manufacturer (2021-2026) & (USD Million)
Table 87. Global PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 88. Market Position of Manufacturers in PSMA Imaging Agent for Prostate Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 89. Head Office and PSMA Imaging Agent for Prostate Cancer Production Site of Key Manufacturer
Table 90. PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
Table 91. PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
Table 92. PSMA Imaging Agent for Prostate Cancer New Market Entrants and Barriers to Market Entry
Table 93. PSMA Imaging Agent for Prostate Cancer Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 95. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2026) & (K Units)
Table 96. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2027-2032) & (K Units)
Table 97. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 98. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 99. Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 100. Global PSMA Imaging Agent for Prostate Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 101. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 102. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 103. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2021-2026) & (USD Million)
Table 104. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Type (2027-2032) & (USD Million)
Table 105. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 106. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 107. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 108. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 109. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2021-2026) & (USD Million)
Table 110. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application (2027-2032) & (USD Million)
Table 111. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 112. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 113. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 114. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 115. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 116. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 117. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 118. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 119. North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 120. North America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 121. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 122. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 123. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 124. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 125. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 126. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 127. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 128. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 129. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 130. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 131. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 132. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 133. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2021-2026) & (K Units)
Table 134. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity by Region (2027-2032) & (K Units)
Table 135. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2021-2026) & (USD Million)
Table 136. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value by Region (2027-2032) & (USD Million)
Table 137. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 138. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 139. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 140. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 141. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 142. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 143. South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 144. South America PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 145. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2021-2026) & (K Units)
Table 146. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Type (2027-2032) & (K Units)
Table 147. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2021-2026) & (K Units)
Table 148. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Application (2027-2032) & (K Units)
Table 149. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2021-2026) & (K Units)
Table 150. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity by Country (2027-2032) & (K Units)
Table 151. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2021-2026) & (USD Million)
Table 152. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value by Country (2027-2032) & (USD Million)
Table 153. PSMA Imaging Agent for Prostate Cancer Raw Material
Table 154. Key Manufacturers of PSMA Imaging Agent for Prostate Cancer Raw Materials
Table 155. PSMA Imaging Agent for Prostate Cancer Typical Distributors
Table 156. PSMA Imaging Agent for Prostate Cancer Typical Customers
LIST OF FIGURES
Figure 1. PSMA Imaging Agent for Prostate Cancer Picture
Figure 2. Global PSMA Imaging Agent for Prostate Cancer Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Type in 2025
Figure 4. 68Ga Examples
Figure 5. 18F Examples
Figure 6. Global PSMA Imaging Agent for Prostate Cancer Revenue by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Figure 7. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Core Carrier Materials in 2025
Figure 8. First Generation Examples
Figure 9. Second Generation Examples
Figure 10. Global PSMA Imaging Agent for Prostate Cancer Revenue by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 11. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Mechanism of Action in 2025
Figure 12. Active Targeting Examples
Figure 13. Passive Targeting Examples
Figure 14. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Application in 2025
Figure 16. Nuclear Medicine and Molecular Imaging Examples
Figure 17. Precision Oncology Diagnostics Examples
Figure 18. Radiopharmaceuticals and Radiopharmaceuticals Examples
Figure 19. Global PSMA Imaging Agent for Prostate Cancer Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global PSMA Imaging Agent for Prostate Cancer Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity (2021-2032) & (K Units)
Figure 22. Global PSMA Imaging Agent for Prostate Cancer Price (2021-2032) & (US$/Unit)
Figure 23. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 PSMA Imaging Agent for Prostate Cancer Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 PSMA Imaging Agent for Prostate Cancer Manufacturer (Revenue) Market Share in 2025
Figure 28. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Region (2021-2032)
Figure 30. North America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 33. South America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 35. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Type (2021-2032)
Figure 37. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 38. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Application (2021-2032)
Figure 40. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 41. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 45. United States PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 53. France PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Region (2021-2032)
Figure 61. China PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 64. India PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 67. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 81. PSMA Imaging Agent for Prostate Cancer Market Drivers
Figure 82. PSMA Imaging Agent for Prostate Cancer Market Restraints
Figure 83. PSMA Imaging Agent for Prostate Cancer Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of PSMA Imaging Agent for Prostate Cancer in 2025
Figure 86. Manufacturing Process Analysis of PSMA Imaging Agent for Prostate Cancer
Figure 87. PSMA Imaging Agent for Prostate Cancer Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
Figure 1. PSMA Imaging Agent for Prostate Cancer Picture
Figure 2. Global PSMA Imaging Agent for Prostate Cancer Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Type in 2025
Figure 4. 68Ga Examples
Figure 5. 18F Examples
Figure 6. Global PSMA Imaging Agent for Prostate Cancer Revenue by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Figure 7. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Core Carrier Materials in 2025
Figure 8. First Generation Examples
Figure 9. Second Generation Examples
Figure 10. Global PSMA Imaging Agent for Prostate Cancer Revenue by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 11. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Mechanism of Action in 2025
Figure 12. Active Targeting Examples
Figure 13. Passive Targeting Examples
Figure 14. Global PSMA Imaging Agent for Prostate Cancer Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Application in 2025
Figure 16. Nuclear Medicine and Molecular Imaging Examples
Figure 17. Precision Oncology Diagnostics Examples
Figure 18. Radiopharmaceuticals and Radiopharmaceuticals Examples
Figure 19. Global PSMA Imaging Agent for Prostate Cancer Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global PSMA Imaging Agent for Prostate Cancer Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity (2021-2032) & (K Units)
Figure 22. Global PSMA Imaging Agent for Prostate Cancer Price (2021-2032) & (US$/Unit)
Figure 23. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Manufacturer in 2025
Figure 24. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Manufacturer in 2025
Figure 25. Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 26. Top 3 PSMA Imaging Agent for Prostate Cancer Manufacturer (Revenue) Market Share in 2025
Figure 27. Top 6 PSMA Imaging Agent for Prostate Cancer Manufacturer (Revenue) Market Share in 2025
Figure 28. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 29. Global PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Region (2021-2032)
Figure 30. North America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 31. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 32. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 33. South America PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 34. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 35. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 36. Global PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Type (2021-2032)
Figure 37. Global PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 38. Global PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 39. Global PSMA Imaging Agent for Prostate Cancer Revenue Market Share by Application (2021-2032)
Figure 40. Global PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 41. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 42. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 43. North America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 44. North America PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 45. United States PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 49. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 50. Europe PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 51. Europe PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 53. France PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 58. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 59. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Region (2021-2032)
Figure 60. Asia-Pacific PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Region (2021-2032)
Figure 61. China PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 64. India PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 67. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 68. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 69. South America PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 70. South America PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 71. Brazil PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 72. Argentina PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 73. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Type (2021-2032)
Figure 74. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Application (2021-2032)
Figure 75. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Sales Quantity Market Share by Country (2021-2032)
Figure 76. Middle East & Africa PSMA Imaging Agent for Prostate Cancer Consumption Value Market Share by Country (2021-2032)
Figure 77. Turkey PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 78. Egypt PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 79. Saudi Arabia PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 80. South Africa PSMA Imaging Agent for Prostate Cancer Consumption Value (2021-2032) & (USD Million)
Figure 81. PSMA Imaging Agent for Prostate Cancer Market Drivers
Figure 82. PSMA Imaging Agent for Prostate Cancer Market Restraints
Figure 83. PSMA Imaging Agent for Prostate Cancer Market Trends
Figure 84. Porters Five Forces Analysis
Figure 85. Manufacturing Cost Structure Analysis of PSMA Imaging Agent for Prostate Cancer in 2025
Figure 86. Manufacturing Process Analysis of PSMA Imaging Agent for Prostate Cancer
Figure 87. PSMA Imaging Agent for Prostate Cancer Industrial Chain
Figure 88. Sales Channel: Direct to End-User vs Distributors
Figure 89. Direct Channel Pros & Cons
Figure 90. Indirect Channel Pros & Cons
Figure 91. Methodology
Figure 92. Research Process and Data Source
